Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)
Department of Health and Human Services National Institutes of Health
Tipo
Research/project funding
Posted on:
Scadenza delle domande:
Expired
Reference Number
PAR-22-032
Reissue of PAR-19-146 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents.
Categories: Education, Health.
Categories: Education, Health.
Stati Uniti